Çanakkale Onsekiz Mart University

comu.edu.tr

Total trials

47

Active

23

Phase 3

0

Total enrollment

4,396

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Inflammation2
  • Geriatric Oncology2
  • Oncology2
  • Airway Complication of Anesthesia2
  • Work Stress1
  • Elective Laparoscopic Cholecystectomy1
  • Dysmenorrhea1
  • Nonpharmalogical Pain Management1

Frequently asked questions about Çanakkale Onsekiz Mart University

How many clinical trials does Çanakkale Onsekiz Mart University have on ClinicalTrials.gov?
Çanakkale Onsekiz Mart University is listed as the lead sponsor on 47 clinical trials in ClinicalTrials.gov, 23 of which are currently active (recruiting, enrolling, or ongoing).
How many of Çanakkale Onsekiz Mart University's trials are in Phase 3?
0 of Çanakkale Onsekiz Mart University's trials are in Phase 3.
What therapeutic areas does Çanakkale Onsekiz Mart University focus on?
Çanakkale Onsekiz Mart University's most-studied conditions on ClinicalTrials.gov are Inflammation, Geriatric Oncology, Oncology, Airway Complication of Anesthesia, Work Stress.